

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * microglial cell activation (GO:0001774) | 4.86430693 |
| 2 | glucuronate metabolic process (GO:0019585) | 4.65542247 |
| 3 | uronic acid metabolic process (GO:0006063) | 4.65542247 |
| 4 | cellular glucuronidation (GO:0052695) | 4.64481156 |
| 5 | drug catabolic process (GO:0042737) | 4.53585798 |
| 6 | * modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.48707682 |
| 7 | * positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.48707682 |
| 8 | * modulation by symbiont of host immune response (GO:0052553) | 4.48707682 |
| 9 | * positive regulation by symbiont of host defense response (GO:0052509) | 4.48707682 |
| 10 | * modulation by symbiont of host defense response (GO:0052031) | 4.48707682 |
| 11 | * modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.48707682 |
| 12 | exogenous drug catabolic process (GO:0042738) | 4.46368708 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 4.29206435 |
| 14 | angiotensin maturation (GO:0002003) | 4.09057036 |
| 15 | flavonoid metabolic process (GO:0009812) | 4.04602417 |
| 16 | regulation of guanylate cyclase activity (GO:0031282) | 4.02673702 |
| 17 | intestinal absorption (GO:0050892) | 3.95496635 |
| 18 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.92991025 |
| 19 | * positive regulation of interferon-alpha production (GO:0032727) | 3.84950166 |
| 20 | drug transmembrane transport (GO:0006855) | 3.84887669 |
| 21 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.80833973 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 3.70173933 |
| 23 | drug metabolic process (GO:0017144) | 3.66425110 |
| 24 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.61924438 |
| 25 | * regulation of interferon-alpha production (GO:0032647) | 3.59950888 |
| 26 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.59658664 |
| 27 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.57840380 |
| 28 | * macrophage activation involved in immune response (GO:0002281) | 3.53898520 |
| 29 | L-amino acid import (GO:0043092) | 3.49970925 |
| 30 | bile acid and bile salt transport (GO:0015721) | 3.49403599 |
| 31 | * regulation of interferon-beta biosynthetic process (GO:0045357) | 3.48840831 |
| 32 | behavioral response to nicotine (GO:0035095) | 3.48501455 |
| 33 | amino acid import (GO:0043090) | 3.45727207 |
| 34 | digestion (GO:0007586) | 3.41164661 |
| 35 | regulation of phospholipase A2 activity (GO:0032429) | 3.40292941 |
| 36 | vitamin biosynthetic process (GO:0009110) | 3.39829673 |
| 37 | urate metabolic process (GO:0046415) | 3.34144585 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32397155 |
| 39 | positive regulation of digestive system process (GO:0060456) | 3.30263676 |
| 40 | sulfate transmembrane transport (GO:1902358) | 3.30139789 |
| 41 | T-helper 1 type immune response (GO:0042088) | 3.30073015 |
| 42 | * macrophage activation (GO:0042116) | 3.28719147 |
| 43 | L-fucose metabolic process (GO:0042354) | 3.28664339 |
| 44 | L-fucose catabolic process (GO:0042355) | 3.28664339 |
| 45 | fucose catabolic process (GO:0019317) | 3.28664339 |
| 46 | arginine metabolic process (GO:0006525) | 3.27382095 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.26298826 |
| 48 | sulfation (GO:0051923) | 3.26189985 |
| 49 | * response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21664618 |
| 50 | * response to host immune response (GO:0052572) | 3.21664618 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19032301 |
| 52 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.18421093 |
| 53 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.15543242 |
| 54 | endocrine process (GO:0050886) | 3.15543242 |
| 55 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.15543242 |
| 56 | tryptophan catabolic process (GO:0006569) | 3.14307173 |
| 57 | indole-containing compound catabolic process (GO:0042436) | 3.14307173 |
| 58 | indolalkylamine catabolic process (GO:0046218) | 3.14307173 |
| 59 | pinocytosis (GO:0006907) | 3.13808545 |
| 60 | transepithelial transport (GO:0070633) | 3.12972207 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.12365515 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.12365515 |
| 63 | regulation of monocyte chemotaxis (GO:0090025) | 3.11401197 |
| 64 | bile acid metabolic process (GO:0008206) | 3.10711104 |
| 65 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03988371 |
| 66 | * response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.02053006 |
| 67 | * response to host (GO:0075136) | 3.02053006 |
| 68 | * response to host defenses (GO:0052200) | 3.02053006 |
| 69 | response to peptidoglycan (GO:0032494) | 2.99799072 |
| 70 | protein polyglutamylation (GO:0018095) | 2.99574172 |
| 71 | response to type I interferon (GO:0034340) | 2.99569791 |
| 72 | type I interferon signaling pathway (GO:0060337) | 2.99496864 |
| 73 | cellular response to type I interferon (GO:0071357) | 2.99496864 |
| 74 | oligosaccharide catabolic process (GO:0009313) | 2.99467035 |
| 75 | glycerol metabolic process (GO:0006071) | 2.99460096 |
| 76 | L-ascorbic acid metabolic process (GO:0019852) | 2.96098476 |
| 77 | cobalamin metabolic process (GO:0009235) | 2.93898689 |
| 78 | phenol-containing compound catabolic process (GO:0019336) | 2.93404013 |
| 79 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.92970552 |
| 80 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.92970552 |
| 81 | drug transport (GO:0015893) | 2.91126283 |
| 82 | indolalkylamine metabolic process (GO:0006586) | 2.91023112 |
| 83 | cellular response to interferon-alpha (GO:0035457) | 2.88035674 |
| 84 | establishment of protein localization to Golgi (GO:0072600) | 2.87766506 |
| 85 | sperm motility (GO:0030317) | 2.87004948 |
| 86 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.86668320 |
| 87 | estrogen biosynthetic process (GO:0006703) | 2.85168286 |
| 88 | response to interferon-alpha (GO:0035455) | 2.84358567 |
| 89 | ethanol oxidation (GO:0006069) | 2.84124514 |
| 90 | intracellular pH reduction (GO:0051452) | 2.82215750 |
| 91 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.81305840 |
| 92 | low-density lipoprotein particle remodeling (GO:0034374) | 2.80964861 |
| 93 | protein targeting to Golgi (GO:0000042) | 2.80242463 |
| 94 | tryptophan metabolic process (GO:0006568) | 2.80210116 |
| 95 | phagocytosis, engulfment (GO:0006911) | 2.77666528 |
| 96 | sodium-independent organic anion transport (GO:0043252) | 2.76382142 |
| 97 | positive regulation of icosanoid secretion (GO:0032305) | 2.75295329 |
| 98 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.74795807 |
| 99 | positive regulation of antigen processing and presentation (GO:0002579) | 2.74556383 |
| 100 | glycosphingolipid catabolic process (GO:0046479) | 2.74397821 |
| 101 | positive regulation of fatty acid transport (GO:2000193) | 2.74229102 |
| 102 | hormone catabolic process (GO:0042447) | 2.73049876 |
| 103 | phenylpropanoid metabolic process (GO:0009698) | 2.73016269 |
| 104 | transcytosis (GO:0045056) | 2.71744465 |
| 105 | axoneme assembly (GO:0035082) | 2.70244748 |
| 106 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.69963413 |
| 107 | S-adenosylmethionine metabolic process (GO:0046500) | 2.69058495 |
| 108 | positive regulation of macrophage cytokine production (GO:0060907) | 2.67806679 |
| 109 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67249607 |
| 110 | parturition (GO:0007567) | 2.65869351 |
| 111 | organic cation transport (GO:0015695) | 2.65815494 |
| 112 | sphingolipid catabolic process (GO:0030149) | 2.65366066 |
| 113 | sulfur compound transport (GO:0072348) | 2.64942520 |
| 114 | regulation of bile acid biosynthetic process (GO:0070857) | 2.63808178 |
| 115 | epithelial cilium movement (GO:0003351) | 2.63632256 |
| 116 | apoptotic cell clearance (GO:0043277) | 2.62529609 |
| 117 | oxidative demethylation (GO:0070989) | 2.61994494 |
| 118 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.58819251 |
| 119 | alditol metabolic process (GO:0019400) | 2.57984700 |
| 120 | endothelium development (GO:0003158) | 2.57562821 |
| 121 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.56163472 |
| 122 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.56146590 |
| 123 | sulfate transport (GO:0008272) | 2.55808955 |
| 124 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55720409 |
| 125 | alanine transport (GO:0032328) | 2.55671255 |
| 126 | xenobiotic metabolic process (GO:0006805) | 2.55266812 |
| 127 | omega-hydroxylase P450 pathway (GO:0097267) | 2.55245354 |
| 128 | intestinal cholesterol absorption (GO:0030299) | 2.54395697 |
| 129 | regulation of systemic arterial blood pressure (GO:0003073) | 2.54102466 |
| 130 | membrane raft organization (GO:0031579) | 2.53898165 |
| 131 | C4-dicarboxylate transport (GO:0015740) | 2.53654150 |
| 132 | detection of molecule of bacterial origin (GO:0032490) | 2.53532905 |
| 133 | lipoprotein transport (GO:0042953) | 2.51809789 |
| 134 | regulation of cGMP biosynthetic process (GO:0030826) | 2.51276513 |
| 135 | thyroid hormone metabolic process (GO:0042403) | 2.51049857 |
| 136 | alkaloid metabolic process (GO:0009820) | 2.50609106 |
| 137 | estrogen metabolic process (GO:0008210) | 2.50495128 |
| 138 | chondroitin sulfate catabolic process (GO:0030207) | 2.49192808 |
| 139 | * positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.48937136 |
| 140 | immunoglobulin mediated immune response (GO:0016064) | 2.48174074 |
| 141 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.47480000 |
| 142 | excretion (GO:0007588) | 2.47208832 |
| 143 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.47101761 |
| 144 | primary alcohol metabolic process (GO:0034308) | 2.46192397 |
| 145 | * I-kappaB phosphorylation (GO:0007252) | 2.45719810 |
| 146 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.45659060 |
| 147 | fat-soluble vitamin metabolic process (GO:0006775) | 2.45122668 |
| 148 | cell adhesion mediated by integrin (GO:0033627) | 2.44546233 |
| 149 | kynurenine metabolic process (GO:0070189) | 2.43926232 |
| 150 | ceramide catabolic process (GO:0046514) | 2.43707865 |
| 151 | macroautophagy (GO:0016236) | 2.43385131 |
| 152 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.43003980 |
| 153 | glycolipid catabolic process (GO:0019377) | 2.42870614 |
| 154 | membrane lipid catabolic process (GO:0046466) | 2.41455983 |
| 155 | response to nitrosative stress (GO:0051409) | 2.41441093 |
| 156 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.40774309 |
| 157 | amino-acid betaine metabolic process (GO:0006577) | 2.39416744 |
| 158 | platelet dense granule organization (GO:0060155) | 2.39147752 |
| 159 | positive regulation of fatty acid oxidation (GO:0046321) | 2.38954462 |
| 160 | regulation of digestive system process (GO:0044058) | 2.37474852 |
| 161 | * cellular response to exogenous dsRNA (GO:0071360) | 2.37424373 |
| 162 | arginine catabolic process (GO:0006527) | 2.37331033 |
| 163 | alpha-linolenic acid metabolic process (GO:0036109) | 2.36881960 |
| 164 | bile acid biosynthetic process (GO:0006699) | 2.36286072 |
| 165 | positive regulation of response to biotic stimulus (GO:0002833) | 2.35148475 |
| 166 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.35023227 |
| 167 | pH reduction (GO:0045851) | 2.34475943 |
| 168 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.34185965 |
| 169 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.34129138 |
| 170 | negative regulation of tissue remodeling (GO:0034104) | 2.32535412 |
| 171 | * positive regulation of interferon-beta production (GO:0032728) | 2.31910180 |
| 172 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.31546809 |
| 173 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.28908395 |
| 174 | negative regulation of mast cell activation (GO:0033004) | 2.27670456 |
| 175 | virion attachment to host cell (GO:0019062) | 2.27599601 |
| 176 | adhesion of symbiont to host cell (GO:0044650) | 2.27599601 |
| 177 | cytokine secretion (GO:0050663) | 2.26713151 |
| 178 | regulation of antigen processing and presentation (GO:0002577) | 2.24786515 |
| 179 | neutrophil activation involved in immune response (GO:0002283) | 2.23759437 |
| 180 | respiratory burst (GO:0045730) | 2.23634768 |
| 181 | positive regulation of phagocytosis (GO:0050766) | 2.22123123 |
| 182 | adhesion of symbiont to host (GO:0044406) | 2.21587547 |
| 183 | reverse cholesterol transport (GO:0043691) | 2.21287332 |
| 184 | ruffle organization (GO:0031529) | 2.21029062 |
| 185 | positive regulation of interleukin-17 production (GO:0032740) | 2.16833737 |
| 186 | lipoprotein metabolic process (GO:0042157) | 2.16079463 |
| 187 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.13344464 |
| 188 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.11741918 |
| 189 | protein-lipid complex remodeling (GO:0034368) | 2.11407986 |
| 190 | macromolecular complex remodeling (GO:0034367) | 2.11407986 |
| 191 | plasma lipoprotein particle remodeling (GO:0034369) | 2.11407986 |
| 192 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.10770046 |
| 193 | response to cholesterol (GO:0070723) | 2.08902954 |
| 194 | linoleic acid metabolic process (GO:0043651) | 2.08122272 |
| 195 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.08107844 |
| 196 | response to muramyl dipeptide (GO:0032495) | 2.07203787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.17109635 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.00305422 |
| 3 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.13930724 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.01475592 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.89154415 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.77516979 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77094164 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50000215 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 2.35414867 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.33550781 |
| 11 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.32067598 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28541825 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 2.25920086 |
| 14 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.16663476 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.12710424 |
| 16 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.03647325 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02809186 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.02171975 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.00487791 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.94346647 |
| 21 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.93869089 |
| 22 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93749938 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86218317 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81275543 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80296089 |
| 26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78937442 |
| 27 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.74803447 |
| 28 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.71889671 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.70988424 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.69860347 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66080375 |
| 32 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.63539568 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62388032 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61420132 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.60194848 |
| 36 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.59464725 |
| 37 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.57450872 |
| 38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.57450872 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56818771 |
| 40 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.56588051 |
| 41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.56088869 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.53679597 |
| 43 | FUS_26573619_Chip-Seq_HEK293_Human | 1.53195983 |
| 44 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.51638209 |
| 45 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.50830922 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50744043 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50569168 |
| 48 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.48075540 |
| 49 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.47216881 |
| 50 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43611501 |
| 51 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43360464 |
| 52 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42019798 |
| 53 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41793298 |
| 54 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.41542077 |
| 55 | RXR_22108803_ChIP-Seq_LS180_Human | 1.40295916 |
| 56 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40099504 |
| 57 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40032484 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.39219661 |
| 59 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.38026955 |
| 60 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37535046 |
| 61 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.37395445 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.36096736 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36058041 |
| 64 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35703405 |
| 65 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.34972176 |
| 66 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.34940346 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.34218463 |
| 68 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33046703 |
| 69 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.31436085 |
| 70 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.31436085 |
| 71 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.31336398 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.31336398 |
| 73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.30856298 |
| 74 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30450399 |
| 75 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.29863486 |
| 76 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29739091 |
| 77 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28122973 |
| 78 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28029160 |
| 79 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.27936462 |
| 80 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.27921198 |
| 81 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.27921198 |
| 82 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25967547 |
| 83 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.22440754 |
| 84 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.22138417 |
| 85 | AR_20517297_ChIP-Seq_VCAP_Human | 1.21648181 |
| 86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21228985 |
| 87 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21151661 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20946842 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19655436 |
| 90 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19182599 |
| 91 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16774553 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16483379 |
| 93 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16197113 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15896223 |
| 95 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14943309 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14586551 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.14175342 |
| 98 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.13660154 |
| 99 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.13474324 |
| 100 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.12601425 |
| 101 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11970599 |
| 102 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.11232961 |
| 103 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10693835 |
| 104 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.10105412 |
| 105 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10063507 |
| 106 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09741518 |
| 107 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08921471 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08602815 |
| 109 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.07695799 |
| 110 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07555403 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 1.06157202 |
| 112 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05921324 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05623727 |
| 114 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05614514 |
| 115 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05375395 |
| 116 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.05299687 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05184125 |
| 118 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.04659036 |
| 119 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04612408 |
| 120 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03782686 |
| 121 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.03762566 |
| 122 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03549021 |
| 123 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03492378 |
| 124 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.03187324 |
| 125 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03177586 |
| 126 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02982365 |
| 127 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02640768 |
| 128 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02624170 |
| 129 | NCOR_22424771_ChIP-Seq_293T_Human | 1.02259215 |
| 130 | * FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.01684335 |
| 131 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01591100 |
| 132 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01297416 |
| 133 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.01286273 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.01228684 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01049975 |
| 136 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.00897124 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00651890 |
| 138 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.00420823 |
| 139 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.99252561 |
| 140 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.98969570 |
| 141 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97725176 |
| 142 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97614966 |
| 143 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.97503154 |
| 144 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.97271953 |
| 145 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.97235671 |
| 146 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97227173 |
| 147 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97050482 |
| 148 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96968951 |
| 149 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96739141 |
| 150 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95117094 |
| 151 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.91922587 |
| 152 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.91838770 |
| 153 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91199506 |
| 154 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90053603 |
| 155 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89088867 |
| 156 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.89026901 |
| 157 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87357295 |
| 158 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86593954 |
| 159 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.86448486 |
| 160 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.85999413 |
| 161 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85827201 |
| 162 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85688454 |
| 163 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83180786 |
| 164 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.82647789 |
| 165 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.82647789 |
| 166 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82253873 |
| 167 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81118801 |
| 168 | AR_25329375_ChIP-Seq_VCAP_Human | 0.80996471 |
| 169 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79409577 |
| 170 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.78974676 |
| 171 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.76473627 |
| 172 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75651635 |
| 173 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.74516490 |
| 174 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74465470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.76808329 |
| 2 | MP0005365_abnormal_bile_salt | 3.52317052 |
| 3 | MP0002876_abnormal_thyroid_physiology | 3.48160919 |
| 4 | MP0003195_calcinosis | 3.25819705 |
| 5 | MP0006082_CNS_inflammation | 3.12718235 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.03144735 |
| 7 | MP0003690_abnormal_glial_cell | 3.01718495 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.01378078 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.55918011 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.47036759 |
| 11 | MP0003303_peritoneal_inflammation | 2.38582199 |
| 12 | MP0003724_increased_susceptibility_to | 2.37192929 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.34705304 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.34244630 |
| 15 | MP0009384_cardiac_valve_regurgitation | 2.31892698 |
| 16 | MP0003075_altered_response_to | 2.29575402 |
| 17 | MP0002254_reproductive_system_inflammat | 2.26447180 |
| 18 | MP0001853_heart_inflammation | 2.16029784 |
| 19 | MP0005167_abnormal_blood-brain_barrier | 2.15646818 |
| 20 | MP0001485_abnormal_pinna_reflex | 2.15529572 |
| 21 | MP0003172_abnormal_lysosome_physiology | 2.12193274 |
| 22 | MP0009785_altered_susceptibility_to | 2.08477018 |
| 23 | * MP0002419_abnormal_innate_immunity | 2.04662505 |
| 24 | MP0004043_abnormal_pH_regulation | 2.00661032 |
| 25 | MP0009840_abnormal_foam_cell | 2.00007972 |
| 26 | MP0009764_decreased_sensitivity_to | 1.91616464 |
| 27 | MP0003436_decreased_susceptibility_to | 1.90995127 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.87042082 |
| 29 | MP0003646_muscle_fatigue | 1.86092968 |
| 30 | MP0005360_urolithiasis | 1.86061403 |
| 31 | MP0003878_abnormal_ear_physiology | 1.84408498 |
| 32 | MP0005377_hearing/vestibular/ear_phenot | 1.84408498 |
| 33 | MP0002102_abnormal_ear_morphology | 1.83651944 |
| 34 | MP0003879_abnormal_hair_cell | 1.76138750 |
| 35 | MP0003279_aneurysm | 1.74503918 |
| 36 | MP0001790_abnormal_immune_system | 1.74302207 |
| 37 | MP0005387_immune_system_phenotype | 1.74302207 |
| 38 | MP0008872_abnormal_physiological_respon | 1.69748896 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.68399080 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.67011378 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.66730770 |
| 42 | MP0004858_abnormal_nervous_system | 1.64153201 |
| 43 | MP0000343_altered_response_to | 1.63105445 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.60905558 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.59770670 |
| 46 | MP0002090_abnormal_vision | 1.59151150 |
| 47 | MP0001958_emphysema | 1.58297671 |
| 48 | MP0001501_abnormal_sleep_pattern | 1.57253765 |
| 49 | MP0003868_abnormal_feces_composition | 1.55771946 |
| 50 | * MP0005025_abnormal_response_to | 1.55712026 |
| 51 | MP0001765_abnormal_ion_homeostasis | 1.53087281 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.51537121 |
| 53 | MP0000230_abnormal_systemic_arterial | 1.50961422 |
| 54 | MP0003183_abnormal_peptide_metabolism | 1.50937230 |
| 55 | MP0005671_abnormal_response_to | 1.50903221 |
| 56 | MP0003252_abnormal_bile_duct | 1.49127631 |
| 57 | MP0005166_decreased_susceptibility_to | 1.47639590 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.47220439 |
| 59 | * MP0002452_abnormal_antigen_presenting | 1.46747955 |
| 60 | MP0005410_abnormal_fertilization | 1.46713231 |
| 61 | MP0003045_fibrosis | 1.43420147 |
| 62 | MP0008775_abnormal_heart_ventricle | 1.42419059 |
| 63 | MP0001879_abnormal_lymphatic_vessel | 1.41660954 |
| 64 | MP0003011_delayed_dark_adaptation | 1.41358448 |
| 65 | MP0004885_abnormal_endolymph | 1.40567964 |
| 66 | MP0005164_abnormal_response_to | 1.40454525 |
| 67 | MP0001881_abnormal_mammary_gland | 1.39651692 |
| 68 | MP0000427_abnormal_hair_cycle | 1.37952212 |
| 69 | MP0005551_abnormal_eye_electrophysiolog | 1.36893221 |
| 70 | MP0010386_abnormal_urinary_bladder | 1.36066548 |
| 71 | MP0010368_abnormal_lymphatic_system | 1.34172823 |
| 72 | MP0000685_abnormal_immune_system | 1.33880780 |
| 73 | MP0005165_increased_susceptibility_to | 1.32362327 |
| 74 | MP0003566_abnormal_cell_adhesion | 1.31572322 |
| 75 | MP0001986_abnormal_taste_sensitivity | 1.30156178 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.28134826 |
| 77 | MP0000538_abnormal_urinary_bladder | 1.26940101 |
| 78 | MP0003718_maternal_effect | 1.24743125 |
| 79 | MP0008438_abnormal_cutaneous_collagen | 1.23781306 |
| 80 | MP0001664_abnormal_digestion | 1.23612716 |
| 81 | MP0004510_myositis | 1.21895642 |
| 82 | MP0004130_abnormal_muscle_cell | 1.20771800 |
| 83 | MP0008469_abnormal_protein_level | 1.20077117 |
| 84 | MP0000249_abnormal_blood_vessel | 1.18341920 |
| 85 | MP0006054_spinal_hemorrhage | 1.14356562 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 1.14323540 |
| 87 | MP0000767_abnormal_smooth_muscle | 1.14183057 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 1.14058018 |
| 89 | MP0001800_abnormal_humoral_immune | 1.13060566 |
| 90 | MP0001873_stomach_inflammation | 1.11365408 |
| 91 | MP0001756_abnormal_urination | 1.10937549 |
| 92 | MP0000383_abnormal_hair_follicle | 1.10389921 |
| 93 | MP0002139_abnormal_hepatobiliary_system | 1.10201153 |
| 94 | MP0000604_amyloidosis | 1.09881776 |
| 95 | MP0005503_abnormal_tendon_morphology | 1.09806142 |
| 96 | MP0005670_abnormal_white_adipose | 1.09763670 |
| 97 | MP0010678_abnormal_skin_adnexa | 1.09699907 |
| 98 | * MP0002723_abnormal_immune_serum | 1.09526581 |
| 99 | * MP0001819_abnormal_immune_cell | 1.08731839 |
| 100 | MP0010234_abnormal_vibrissa_follicle | 1.05804629 |
| 101 | MP0004947_skin_inflammation | 1.05573418 |
| 102 | * MP0001845_abnormal_inflammatory_respons | 1.05531430 |
| 103 | MP0010329_abnormal_lipoprotein_level | 1.05044367 |
| 104 | MP0003828_pulmonary_edema | 1.04361138 |
| 105 | MP0003283_abnormal_digestive_organ | 1.02988494 |
| 106 | MP0003638_abnormal_response/metabolism_ | 1.00621164 |
| 107 | MP0004883_abnormal_blood_vessel | 0.99491775 |
| 108 | MP0001851_eye_inflammation | 0.99248092 |
| 109 | * MP0002420_abnormal_adaptive_immunity | 0.99219863 |
| 110 | MP0004272_abnormal_basement_membrane | 0.99087741 |
| 111 | MP0003091_abnormal_cell_migration | 0.95363705 |
| 112 | MP0010155_abnormal_intestine_physiology | 0.93897131 |
| 113 | MP0005448_abnormal_energy_balance | 0.93797361 |
| 114 | MP0003633_abnormal_nervous_system | 0.93154134 |
| 115 | MP0005083_abnormal_biliary_tract | 0.92203391 |
| 116 | MP0000566_synostosis | 0.91863263 |
| 117 | MP0004215_abnormal_myocardial_fiber | 0.90914791 |
| 118 | MP0001915_intracranial_hemorrhage | 0.90606067 |
| 119 | MP0002166_altered_tumor_susceptibility | 0.90181255 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.87975211 |
| 121 | MP0005332_abnormal_amino_acid | 0.86948882 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.86830245 |
| 123 | MP0002006_tumorigenesis | 0.85826838 |
| 124 | MP0005171_absent_coat_pigmentation | 0.85770645 |
| 125 | MP0001764_abnormal_homeostasis | 0.85736620 |
| 126 | MP0003448_altered_tumor_morphology | 0.85338165 |
| 127 | MP0004147_increased_porphyrin_level | 0.85184683 |
| 128 | MP0008877_abnormal_DNA_methylation | 0.84844774 |
| 129 | MP0003866_abnormal_defecation | 0.83736845 |
| 130 | MP0005390_skeleton_phenotype | 0.83660087 |
| 131 | MP0009763_increased_sensitivity_to | 0.82833601 |
| 132 | MP0005647_abnormal_sex_gland | 0.82573234 |
| 133 | MP0000372_irregular_coat_pigmentation | 0.82008916 |
| 134 | MP0003806_abnormal_nucleotide_metabolis | 0.81778441 |
| 135 | MP0005379_endocrine/exocrine_gland_phen | 0.80546147 |
| 136 | MP0009115_abnormal_fat_cell | 0.80544307 |
| 137 | MP0002160_abnormal_reproductive_system | 0.80128264 |
| 138 | MP0005319_abnormal_enzyme/_coenzyme | 0.79507905 |
| 139 | MP0001666_abnormal_nutrient_absorption | 0.79506916 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.78776600 |
| 141 | MP0008004_abnormal_stomach_pH | 0.78557550 |
| 142 | MP0005389_reproductive_system_phenotype | 0.77760096 |
| 143 | MP0004484_altered_response_of | 0.77569360 |
| 144 | MP0009379_abnormal_foot_pigmentation | 0.76761749 |
| 145 | MP0003453_abnormal_keratinocyte_physiol | 0.76653923 |
| 146 | MP0001663_abnormal_digestive_system | 0.75815051 |
| 147 | MP0006138_congestive_heart_failure | 0.75793245 |
| 148 | MP0002928_abnormal_bile_duct | 0.75636668 |
| 149 | MP0000609_abnormal_liver_physiology | 0.74276911 |
| 150 | MP0002136_abnormal_kidney_physiology | 0.72887392 |
| 151 | MP0005666_abnormal_adipose_tissue | 0.72865088 |
| 152 | MP0002118_abnormal_lipid_homeostasis | 0.72698938 |
| 153 | MP0005084_abnormal_gallbladder_morpholo | 0.72381459 |
| 154 | MP0009697_abnormal_copulation | 0.71833231 |
| 155 | MP0002163_abnormal_gland_morphology | 0.71796954 |
| 156 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71112352 |
| 157 | MP0005395_other_phenotype | 0.65998557 |
| 158 | MP0004742_abnormal_vestibular_system | 0.65023976 |
| 159 | MP0005275_abnormal_skin_tensile | 0.63109859 |
| 160 | MP0005645_abnormal_hypothalamus_physiol | 0.61741374 |
| 161 | MP0005646_abnormal_pituitary_gland | 0.59964412 |
| 162 | MP0005334_abnormal_fat_pad | 0.59351967 |
| 163 | MP0009642_abnormal_blood_homeostasis | 0.57886468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.97482354 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.83808160 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.36727527 |
| 4 | Onycholysis (HP:0001806) | 4.52224543 |
| 5 | Loss of speech (HP:0002371) | 4.13902934 |
| 6 | Decreased circulating renin level (HP:0003351) | 4.06062388 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.01386398 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.01386398 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 4.01386398 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 3.93431932 |
| 11 | Congenital sensorineural hearing impairment (HP:0008527) | 3.47524584 |
| 12 | Nephritis (HP:0000123) | 3.45828745 |
| 13 | Tetraparesis (HP:0002273) | 3.37192709 |
| 14 | Confusion (HP:0001289) | 3.36153657 |
| 15 | Chronic hepatic failure (HP:0100626) | 3.36041940 |
| 16 | Metabolic alkalosis (HP:0200114) | 3.34870904 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.34578880 |
| 18 | Abnormality of the axillary hair (HP:0100134) | 3.26441535 |
| 19 | Abnormality of secondary sexual hair (HP:0009888) | 3.26441535 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.24792809 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.24074527 |
| 22 | Abnormality of macular pigmentation (HP:0008002) | 3.23878343 |
| 23 | Pancreatic cysts (HP:0001737) | 3.22219539 |
| 24 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.17282820 |
| 25 | Aplasia of the phalanges of the hand (HP:0009802) | 3.17282820 |
| 26 | Aplasia involving bones of the extremities (HP:0009825) | 3.17282820 |
| 27 | Fat malabsorption (HP:0002630) | 3.14579718 |
| 28 | Hyperactive renin-angiotensin system (HP:0000841) | 3.13593280 |
| 29 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.12192649 |
| 30 | Abnormality of renin-angiotensin system (HP:0000847) | 3.10251116 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.07203027 |
| 32 | Mucopolysacchariduria (HP:0008155) | 3.07203027 |
| 33 | Hematochezia (HP:0002573) | 3.06242390 |
| 34 | Abnormality of complement system (HP:0005339) | 3.05226668 |
| 35 | Abnormality of vitamin B metabolism (HP:0004340) | 3.01537670 |
| 36 | Abnormality of the renal cortex (HP:0011035) | 3.01027296 |
| 37 | Myocardial infarction (HP:0001658) | 3.00674925 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.95297279 |
| 39 | Glomerulonephritis (HP:0000099) | 2.94875495 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.89862765 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.89862765 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.89862765 |
| 43 | Nephronophthisis (HP:0000090) | 2.87165592 |
| 44 | Decreased central vision (HP:0007663) | 2.87040711 |
| 45 | Abnormality of urine glucose concentration (HP:0011016) | 2.83871143 |
| 46 | Glycosuria (HP:0003076) | 2.83871143 |
| 47 | Vacuolated lymphocytes (HP:0001922) | 2.83683561 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.81844411 |
| 49 | Abnormality of the renal medulla (HP:0100957) | 2.80400461 |
| 50 | Tubular atrophy (HP:0000092) | 2.77848710 |
| 51 | Chronic otitis media (HP:0000389) | 2.76602529 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.74125170 |
| 53 | Pancreatic fibrosis (HP:0100732) | 2.73792224 |
| 54 | Abnormality of midbrain morphology (HP:0002418) | 2.71264035 |
| 55 | Molar tooth sign on MRI (HP:0002419) | 2.71264035 |
| 56 | Steatorrhea (HP:0002570) | 2.69998069 |
| 57 | Chorioretinal atrophy (HP:0000533) | 2.69961477 |
| 58 | Autoimmune thrombocytopenia (HP:0001973) | 2.69759831 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.69020270 |
| 60 | Complement deficiency (HP:0004431) | 2.67919039 |
| 61 | Basal ganglia calcification (HP:0002135) | 2.66927267 |
| 62 | Esophageal varix (HP:0002040) | 2.65321372 |
| 63 | Alkalosis (HP:0001948) | 2.64807798 |
| 64 | Pigmentary retinal degeneration (HP:0001146) | 2.62506262 |
| 65 | Arterial tortuosity (HP:0005116) | 2.61045050 |
| 66 | True hermaphroditism (HP:0010459) | 2.57400433 |
| 67 | Hypobetalipoproteinemia (HP:0003563) | 2.54105856 |
| 68 | Progressive visual loss (HP:0000529) | 2.52000406 |
| 69 | Axonal loss (HP:0003447) | 2.50231217 |
| 70 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.49638522 |
| 71 | Abnormality of vitamin metabolism (HP:0100508) | 2.49045414 |
| 72 | Interstitial pulmonary disease (HP:0006530) | 2.46330225 |
| 73 | Abnormality of nail color (HP:0100643) | 2.45912159 |
| 74 | Polydipsia (HP:0001959) | 2.43923079 |
| 75 | Abnormal drinking behavior (HP:0030082) | 2.43923079 |
| 76 | Keratoconus (HP:0000563) | 2.40694423 |
| 77 | Increased corneal curvature (HP:0100692) | 2.40694423 |
| 78 | Tubulointerstitial nephritis (HP:0001970) | 2.40240832 |
| 79 | Hyperglycinuria (HP:0003108) | 2.40119203 |
| 80 | Hypoproteinemia (HP:0003075) | 2.38571597 |
| 81 | Abnormal albumin level (HP:0012116) | 2.37610783 |
| 82 | Hypoalbuminemia (HP:0003073) | 2.37610783 |
| 83 | Craniofacial hyperostosis (HP:0004493) | 2.37262224 |
| 84 | Vascular calcification (HP:0004934) | 2.36659592 |
| 85 | Abnormality of macrophages (HP:0004311) | 2.36404281 |
| 86 | Hyperaldosteronism (HP:0000859) | 2.36019860 |
| 87 | Vascular tortuosity (HP:0004948) | 2.35104039 |
| 88 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.32830067 |
| 89 | Abnormality of glycine metabolism (HP:0010895) | 2.32830067 |
| 90 | Abnormality of renal excretion (HP:0011036) | 2.32654833 |
| 91 | Adactyly (HP:0009776) | 2.31288325 |
| 92 | Neurofibrillary tangles (HP:0002185) | 2.30890472 |
| 93 | Increased purine levels (HP:0004368) | 2.30155575 |
| 94 | Hyperuricemia (HP:0002149) | 2.30155575 |
| 95 | Cerebral palsy (HP:0100021) | 2.29854261 |
| 96 | Focal segmental glomerulosclerosis (HP:0000097) | 2.29295938 |
| 97 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.28812005 |
| 98 | Amyloidosis (HP:0011034) | 2.27482033 |
| 99 | Large for gestational age (HP:0001520) | 2.25903219 |
| 100 | Thick nail (HP:0001805) | 2.23113180 |
| 101 | Congenital stationary night blindness (HP:0007642) | 2.22337509 |
| 102 | Cardiovascular calcification (HP:0011915) | 2.20800650 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 2.19656532 |
| 104 | Colitis (HP:0002583) | 2.18867548 |
| 105 | Abnormality of potassium homeostasis (HP:0011042) | 2.18030968 |
| 106 | Abnormality of chloride homeostasis (HP:0011422) | 2.16651426 |
| 107 | Abnormal urine output (HP:0012590) | 2.15588149 |
| 108 | Conjugated hyperbilirubinemia (HP:0002908) | 2.14813227 |
| 109 | Hyperkalemia (HP:0002153) | 2.14745290 |
| 110 | Retinal atrophy (HP:0001105) | 2.14731371 |
| 111 | Cranial hyperostosis (HP:0004437) | 2.14039483 |
| 112 | Hypothermia (HP:0002045) | 2.13948973 |
| 113 | Pendular nystagmus (HP:0012043) | 2.13442907 |
| 114 | Congenital, generalized hypertrichosis (HP:0004540) | 2.09600425 |
| 115 | Malnutrition (HP:0004395) | 2.08539629 |
| 116 | Urticaria (HP:0001025) | 2.07643764 |
| 117 | Vasculitis (HP:0002633) | 2.07250641 |
| 118 | Hypokalemia (HP:0002900) | 2.05735993 |
| 119 | Renal cortical cysts (HP:0000803) | 2.05562529 |
| 120 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.05255823 |
| 121 | Absent/shortened dynein arms (HP:0200106) | 2.05255823 |
| 122 | Metabolic acidosis (HP:0001942) | 2.04759175 |
| 123 | Blepharitis (HP:0000498) | 2.03528890 |
| 124 | Hypoalphalipoproteinemia (HP:0003233) | 2.02839329 |
| 125 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.01538153 |
| 126 | Macular degeneration (HP:0000608) | 2.01118056 |
| 127 | Cystic liver disease (HP:0006706) | 2.00946811 |
| 128 | Premature loss of primary teeth (HP:0006323) | 1.98840633 |
| 129 | Tubulointerstitial abnormality (HP:0001969) | 1.98228147 |
| 130 | J-shaped sella turcica (HP:0002680) | 1.96725213 |
| 131 | Periodontitis (HP:0000704) | 1.96605195 |
| 132 | Diplopia (HP:0000651) | 1.95371378 |
| 133 | Abnormality of binocular vision (HP:0011514) | 1.95371378 |
| 134 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.94652259 |
| 135 | Polyuria (HP:0000103) | 1.94161719 |
| 136 | Poor head control (HP:0002421) | 1.92727505 |
| 137 | Xerostomia (HP:0000217) | 1.91969268 |
| 138 | Bone cyst (HP:0012062) | 1.91424829 |
| 139 | Congenital hepatic fibrosis (HP:0002612) | 1.91080591 |
| 140 | Glomerulosclerosis (HP:0000096) | 1.90915480 |
| 141 | Abnormal biliary tract physiology (HP:0012439) | 1.90738085 |
| 142 | Bile duct proliferation (HP:0001408) | 1.90738085 |
| 143 | Xanthomatosis (HP:0000991) | 1.90672716 |
| 144 | Polycythemia (HP:0001901) | 1.89951051 |
| 145 | Methylmalonic aciduria (HP:0012120) | 1.88467217 |
| 146 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.87267992 |
| 147 | Abnormality of proline metabolism (HP:0010907) | 1.87243064 |
| 148 | Hydroxyprolinuria (HP:0003080) | 1.87243064 |
| 149 | Mediastinal lymphadenopathy (HP:0100721) | 1.87203673 |
| 150 | Osteolytic defects of the hand bones (HP:0009699) | 1.86771409 |
| 151 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.86771409 |
| 152 | Hemorrhage of the eye (HP:0011885) | 1.86096723 |
| 153 | Azoospermia (HP:0000027) | 1.85252806 |
| 154 | Plantar hyperkeratosis (HP:0007556) | 1.85243714 |
| 155 | Hyperammonemia (HP:0001987) | 1.85137349 |
| 156 | Stage 5 chronic kidney disease (HP:0003774) | 1.83724954 |
| 157 | Aortic aneurysm (HP:0004942) | 1.83569475 |
| 158 | Tubulointerstitial fibrosis (HP:0005576) | 1.83425352 |
| 159 | Pancreatitis (HP:0001733) | 1.83205861 |
| 160 | Cerebral aneurysm (HP:0004944) | 1.82333723 |
| 161 | Arterial thrombosis (HP:0004420) | 1.81860794 |
| 162 | Mitral stenosis (HP:0001718) | 1.81437611 |
| 163 | Emphysema (HP:0002097) | 1.79369798 |
| 164 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.78956656 |
| 165 | Chronic sinusitis (HP:0011109) | 1.78939313 |
| 166 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.78938193 |
| 167 | Myositis (HP:0100614) | 1.78730521 |
| 168 | Recurrent skin infections (HP:0001581) | 1.78508689 |
| 169 | Hyperlipoproteinemia (HP:0010980) | 1.77672131 |
| 170 | Enlarged kidneys (HP:0000105) | 1.77294565 |
| 171 | Atrophic scars (HP:0001075) | 1.76980066 |
| 172 | Disinhibition (HP:0000734) | 1.75947797 |
| 173 | Orchitis (HP:0100796) | 1.74934845 |
| 174 | Deformed sella turcica (HP:0002681) | 1.74514465 |
| 175 | Short hallux (HP:0010109) | 1.74298633 |
| 176 | Polygenic inheritance (HP:0010982) | 1.73827152 |
| 177 | Hepatosplenomegaly (HP:0001433) | 1.73131416 |
| 178 | Chronic diarrhea (HP:0002028) | 1.72995567 |
| 179 | Palmoplantar hyperkeratosis (HP:0000972) | 1.71894450 |
| 180 | Clumsiness (HP:0002312) | 1.71691260 |
| 181 | Potter facies (HP:0002009) | 1.71680893 |
| 182 | Facial shape deformation (HP:0011334) | 1.71680893 |
| 183 | Acrocyanosis (HP:0001063) | 1.71525462 |
| 184 | Alopecia of scalp (HP:0002293) | 1.69963043 |
| 185 | Homocystinuria (HP:0002156) | 1.68977633 |
| 186 | Abnormality of homocysteine metabolism (HP:0010919) | 1.68977633 |
| 187 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.68428761 |
| 188 | Cardiomegaly (HP:0001640) | 1.67841578 |
| 189 | Gingivitis (HP:0000230) | 1.66375693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TGFBR2 | 3.80177138 |
| 2 | MUSK | 3.72953098 |
| 3 | ACVR1B | 3.43904961 |
| 4 | TYK2 | 2.95742394 |
| 5 | ERN1 | 2.75100519 |
| 6 | STK39 | 2.71877459 |
| 7 | LATS1 | 2.55333078 |
| 8 | ADRBK2 | 2.47618056 |
| 9 | OXSR1 | 2.44103121 |
| 10 | MAP4K2 | 2.41913491 |
| 11 | JAK1 | 2.36617745 |
| 12 | IRAK3 | 2.30537975 |
| 13 | TRIB3 | 2.26595521 |
| 14 | MAP3K14 | 2.26081088 |
| 15 | TBK1 | 2.24933580 |
| 16 | NEK9 | 2.06273437 |
| 17 | NUAK1 | 2.03730445 |
| 18 | PINK1 | 2.01765444 |
| 19 | WNK4 | 1.98602521 |
| 20 | BLK | 1.94702254 |
| 21 | CSF1R | 1.88550494 |
| 22 | KIT | 1.77534616 |
| 23 | IRAK4 | 1.77361135 |
| 24 | FGFR3 | 1.75555543 |
| 25 | MST1R | 1.72625813 |
| 26 | SIK1 | 1.70809358 |
| 27 | FGFR4 | 1.68890920 |
| 28 | PLK4 | 1.67686319 |
| 29 | MAP4K1 | 1.62019015 |
| 30 | TIE1 | 1.60728056 |
| 31 | IKBKE | 1.59907898 |
| 32 | FRK | 1.54664886 |
| 33 | EPHB1 | 1.41512639 |
| 34 | MATK | 1.39112851 |
| 35 | CAMK1D | 1.38188967 |
| 36 | JAK3 | 1.37564946 |
| 37 | CSK | 1.34019584 |
| 38 | WNK3 | 1.29518005 |
| 39 | STK38L | 1.26423141 |
| 40 | CAMKK2 | 1.26090846 |
| 41 | PTK6 | 1.23841826 |
| 42 | MST4 | 1.23034028 |
| 43 | MAP2K6 | 1.22292178 |
| 44 | KDR | 1.20006216 |
| 45 | GRK7 | 1.18772539 |
| 46 | TLK1 | 1.15950794 |
| 47 | ADRBK1 | 1.15418496 |
| 48 | MYLK | 1.15364752 |
| 49 | IKBKB | 1.14269440 |
| 50 | MAP3K12 | 1.11826527 |
| 51 | TAOK3 | 1.10482095 |
| 52 | GRK1 | 1.09638140 |
| 53 | RIPK1 | 1.08833691 |
| 54 | TXK | 1.06903006 |
| 55 | MAP3K13 | 1.06013834 |
| 56 | CAMK1G | 1.03578063 |
| 57 | STK3 | 1.02632704 |
| 58 | BMX | 1.02405920 |
| 59 | STK10 | 1.02377173 |
| 60 | AKT3 | 0.99293014 |
| 61 | ZAK | 0.98182493 |
| 62 | STK24 | 0.97174752 |
| 63 | ERBB3 | 0.95725548 |
| 64 | RIPK4 | 0.95586908 |
| 65 | MAPKAPK3 | 0.94861396 |
| 66 | JAK2 | 0.93285306 |
| 67 | BCR | 0.92754547 |
| 68 | EPHA2 | 0.91627837 |
| 69 | TRIM28 | 0.89960339 |
| 70 | IGF1R | 0.89909612 |
| 71 | LMTK2 | 0.88327219 |
| 72 | LYN | 0.87812522 |
| 73 | MAPK12 | 0.86968676 |
| 74 | PLK2 | 0.86721620 |
| 75 | FGR | 0.86494352 |
| 76 | PRKAA2 | 0.84668024 |
| 77 | GRK5 | 0.83465424 |
| 78 | BMPR1B | 0.82040549 |
| 79 | INSRR | 0.78585791 |
| 80 | TEC | 0.77638379 |
| 81 | CASK | 0.77001671 |
| 82 | ZAP70 | 0.76326674 |
| 83 | MAPK7 | 0.74988661 |
| 84 | SGK3 | 0.74793565 |
| 85 | PIK3CG | 0.74033114 |
| 86 | CSNK1A1L | 0.72943558 |
| 87 | BRSK2 | 0.72327089 |
| 88 | LRRK2 | 0.71663060 |
| 89 | NEK6 | 0.70314373 |
| 90 | MAPK15 | 0.69628231 |
| 91 | SYK | 0.67776435 |
| 92 | NTRK2 | 0.67724073 |
| 93 | EPHB2 | 0.66669345 |
| 94 | PBK | 0.66209333 |
| 95 | HCK | 0.64553427 |
| 96 | EPHA3 | 0.63982535 |
| 97 | TRPM7 | 0.63413479 |
| 98 | CSNK1G3 | 0.63155276 |
| 99 | PRKCE | 0.62637297 |
| 100 | DMPK | 0.62437042 |
| 101 | CSNK1G2 | 0.62382781 |
| 102 | DAPK2 | 0.59161306 |
| 103 | PHKG2 | 0.59045557 |
| 104 | PHKG1 | 0.59045557 |
| 105 | PDK1 | 0.58555029 |
| 106 | MET | 0.58551367 |
| 107 | PRKCA | 0.58285495 |
| 108 | SGK2 | 0.57451981 |
| 109 | MAP3K4 | 0.56719560 |
| 110 | PTK2B | 0.56381039 |
| 111 | NTRK1 | 0.56319325 |
| 112 | FER | 0.56224319 |
| 113 | EIF2AK3 | 0.55588872 |
| 114 | PDPK1 | 0.54792452 |
| 115 | EGFR | 0.54407709 |
| 116 | PDK2 | 0.54299242 |
| 117 | CSNK1G1 | 0.54279982 |
| 118 | TNIK | 0.53798975 |
| 119 | PIK3CA | 0.51851217 |
| 120 | PRKCQ | 0.50632796 |
| 121 | ABL1 | 0.49892627 |
| 122 | GRK6 | 0.48355374 |
| 123 | MARK3 | 0.48220370 |
| 124 | MOS | 0.48032935 |
| 125 | IRAK1 | 0.48013134 |
| 126 | PRKD1 | 0.47686514 |
| 127 | CHUK | 0.47309317 |
| 128 | PAK3 | 0.47269239 |
| 129 | BMPR2 | 0.47114442 |
| 130 | PRKACA | 0.46790808 |
| 131 | STK16 | 0.46363327 |
| 132 | NLK | 0.46331177 |
| 133 | PRKG2 | 0.46217691 |
| 134 | EIF2AK2 | 0.46172347 |
| 135 | CAMKK1 | 0.45920308 |
| 136 | TGFBR1 | 0.45451951 |
| 137 | MAPKAPK5 | 0.45203080 |
| 138 | PRKD2 | 0.44047216 |
| 139 | RPS6KA5 | 0.43197431 |
| 140 | MAP3K1 | 0.42477099 |
| 141 | ABL2 | 0.41993635 |
| 142 | MAP3K2 | 0.41388129 |
| 143 | INSR | 0.41198226 |
| 144 | FGFR2 | 0.39332437 |
| 145 | MAPK11 | 0.37632277 |
| 146 | ERBB2 | 0.37599292 |
| 147 | PRKCD | 0.36372514 |
| 148 | PIM2 | 0.36279312 |
| 149 | PRKACG | 0.36101299 |
| 150 | CSNK1A1 | 0.35908999 |
| 151 | DDR2 | 0.35870173 |
| 152 | LCK | 0.35508075 |
| 153 | PRKCG | 0.35202179 |
| 154 | SRC | 0.34993674 |
| 155 | FES | 0.34864853 |
| 156 | ITK | 0.33820993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.27468360 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.78716904 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.56328542 |
| 4 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.51348732 |
| 5 | Retinol metabolism_Homo sapiens_hsa00830 | 2.50218221 |
| 6 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.48421654 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.47510407 |
| 8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.33257025 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.27666435 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.25837491 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.22272404 |
| 12 | Asthma_Homo sapiens_hsa05310 | 2.14331460 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 2.14312857 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.03644099 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.93844961 |
| 16 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.91315439 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.74398331 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.73569981 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68691360 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68449234 |
| 21 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.68314161 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.58816465 |
| 23 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.57004526 |
| 24 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.56028861 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.53316625 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53072525 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.51594958 |
| 28 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.51401790 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51172554 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.48908912 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.48898360 |
| 32 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.48672978 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.46929378 |
| 34 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.43870065 |
| 35 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.43866197 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.40774617 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.35961040 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.34744520 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.33511369 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32353221 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.30570509 |
| 42 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.29673661 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25986486 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.22387769 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.21296316 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.21220736 |
| 47 | * Influenza A_Homo sapiens_hsa05164 | 1.17000393 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14693332 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.14574384 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.14491482 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.11069172 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.08195015 |
| 53 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05037532 |
| 54 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04935456 |
| 55 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01828313 |
| 56 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01723002 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.00447630 |
| 58 | Measles_Homo sapiens_hsa05162 | 0.98207706 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95223106 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.95079999 |
| 61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.94433140 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94266211 |
| 63 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.94064352 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93190116 |
| 65 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93152332 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.92077219 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90565147 |
| 68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90176057 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90110990 |
| 70 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.88002257 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87698196 |
| 72 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87509362 |
| 73 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86417324 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85495180 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82933340 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82106703 |
| 77 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.80643650 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.80098172 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79944619 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.79652133 |
| 81 | * Hepatitis C_Homo sapiens_hsa05160 | 0.79314138 |
| 82 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79185228 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79142772 |
| 84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77256735 |
| 85 | Phototransduction_Homo sapiens_hsa04744 | 0.76949316 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76757132 |
| 87 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76713459 |
| 88 | Adherens junction_Homo sapiens_hsa04520 | 0.76688248 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76082449 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75383774 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73789143 |
| 92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.71968063 |
| 93 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69904151 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.67538086 |
| 95 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67435444 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66940235 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.66859703 |
| 98 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64962343 |
| 99 | Platelet activation_Homo sapiens_hsa04611 | 0.64314611 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63261831 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.62785182 |
| 102 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.62087283 |
| 103 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.61824253 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.61556044 |
| 105 | Phagosome_Homo sapiens_hsa04145 | 0.59665789 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58470506 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57488652 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56601786 |
| 109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56301132 |
| 110 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55558464 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.54820929 |
| 112 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54540473 |
| 113 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.53989804 |
| 114 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53938195 |
| 115 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.52565849 |
| 116 | Insulin resistance_Homo sapiens_hsa04931 | 0.52373362 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50900965 |
| 118 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50798344 |
| 119 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50173636 |
| 120 | * Herpes simplex infection_Homo sapiens_hsa05168 | 0.50131620 |
| 121 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50085257 |
| 122 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47140852 |
| 123 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46908916 |
| 124 | Salivary secretion_Homo sapiens_hsa04970 | 0.46512863 |
| 125 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46492512 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45837435 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.45676137 |
| 128 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45643625 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.43637893 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.43334413 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43276261 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.42720445 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42270749 |
| 134 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.42142727 |
| 135 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41433857 |
| 136 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.40248102 |
| 137 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40181336 |
| 138 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.40075104 |
| 139 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.39133005 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.36340043 |
| 141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30044750 |
| 142 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.26885671 |
| 143 | Renin secretion_Homo sapiens_hsa04924 | 0.22468384 |
| 144 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.22357459 |
| 145 | Insulin secretion_Homo sapiens_hsa04911 | 0.21723667 |
| 146 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.20499608 |
| 147 | Olfactory transduction_Homo sapiens_hsa04740 | 0.19193811 |
| 148 | Taste transduction_Homo sapiens_hsa04742 | 0.14899133 |
| 149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.10940549 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.10350927 |
| 151 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.09840585 |

